Posts

Capillus Leads Innovation & Awareness at the 77th AAD Annual Conference

Capillus Changes Its Name to Curallux

/in /by

Capillus, LLC, a Leading US Medical Device Manufacturer of Photobiomodulation Devices, Changes Its Name to Curallux, LLC

As the Capillus® family of brands continues to grow to serve the needs of its customers, Capillus, LLC has undergone a name change. The Florida company is now Curallux, LLC. The change was inspired by an expansion into new innovative products within the medical device and cosmetic industries. The new name, “Curallux,” stems from Latin words for “healing” and “light.”

The name change will not affect its extensive network of hair restoration physicians, partnerships, current products or any regulatory certifications, while company ownership and operations remain the same. The Capillus® brand will continue to be a hair health brand with various product lines, including the Capillus® brand dedicated to laser therapy for hair, the Cap+® brand encompassing all hair care and cosmetic options and the RXCap+® brand focused on non-laser medical products.

Curallux relies on its physician community to be a sounding board for any type of medical or health questions.

Specifically, the current Capillus® product catalog features three lines of Capillus products:

1. Capillus® Laser Therapy Devices: The Capillus® line of ISO13485 certified medical devices features various FDA-cleared home-use caps to fit varying budgets as well as a clinical unit for dedicated, in-office treatment by physicians.

2. Cap+® & RXCap+® Hair Care Products: Complementing laser products for hair regrowth, the hair care line features FDA-approved minoxidil treatments for men and women, hair health supplements and clinical hair therapy products to gently cleanse, exfoliate and moisturize hair for overall scalp health.

3. Cap+® Keratin Fiber Line: The keratin fiber line is a wonderful cosmetic option for those choosing to conceal areas of thinning hair using a convenient, but temporary, solution.

The Capillus® laser therapy product line has also undergone some name changes to more clearly position its various devices. The former Capillus82™ is now the CapillusUltra™ and the former Capillus202™ is now the CapillusPlus™.

About Curallux LLC

Miami-based Curallux, LLC is a leading ISO-13485 certified US manufacturer of Capillus® brand photobiomodulating medical devices which are FDA-cleared for the treatment of androgenetic alopecia. Capillus laser therapy is clinically proven with published results. Other Capillus products include minoxidil, keratin fibers and hair care.

Low-level light therapy was first approved by the Food and Drug Administration in 2007 for the treatment of mild to moderate male pattern hair loss for a laser comb device designed to regrow hair. The emergence of the Capillus laser therapy cap has revolutionized the use of laser therapy for treatment of hair loss by making laser therapy more accessible and easier to use in order to create the most practical application in hair restoration.

Available today, readers are invited to visit https://www.capillus.com to learn more about the 6-minute per day laser therapy medical devices and hair regrowth products.

Capillus, LLC, a Leading US Medical Device Manufacturer of Photobiomodulation Devices, Changes Its Name to Curallux, LLC

Source

Previous Posts

Capillus Leads Innovation & Awareness at the 77th AAD Annual Conference

Capillus Changes Its Name to Curallux

/in /by

Capillus, LLC, a Leading US Medical Device Manufacturer of Photobiomodulation Devices, Changes Its Name to Curallux, LLC

As the Capillus® family of brands continues to grow to serve the needs of its customers, Capillus, LLC has undergone a name change. The Florida company is now Curallux, LLC. The change was inspired by an expansion into new innovative products within the medical device and cosmetic industries. The new name, “Curallux,” stems from Latin words for “healing” and “light.”

The name change will not affect its extensive network of hair restoration physicians, partnerships, current products or any regulatory certifications, while company ownership and operations remain the same. The Capillus® brand will continue to be a hair health brand with various product lines, including the Capillus® brand dedicated to laser therapy for hair, the Cap+® brand encompassing all hair care and cosmetic options and the RXCap+® brand focused on non-laser medical products.

Curallux relies on its physician community to be a sounding board for any type of medical or health questions.

Specifically, the current Capillus® product catalog features three lines of Capillus products:

1. Capillus® Laser Therapy Devices: The Capillus® line of ISO13485 certified medical devices features various FDA-cleared home-use caps to fit varying budgets as well as a clinical unit for dedicated, in-office treatment by physicians.

2. Cap+® & RXCap+® Hair Care Products: Complementing laser products for hair regrowth, the hair care line features FDA-approved minoxidil treatments for men and women, hair health supplements and clinical hair therapy products to gently cleanse, exfoliate and moisturize hair for overall scalp health.

3. Cap+® Keratin Fiber Line: The keratin fiber line is a wonderful cosmetic option for those choosing to conceal areas of thinning hair using a convenient, but temporary, solution.

The Capillus® laser therapy product line has also undergone some name changes to more clearly position its various devices. The former Capillus82™ is now the CapillusUltra™ and the former Capillus202™ is now the CapillusPlus™.

About Curallux LLC

Miami-based Curallux, LLC is a leading ISO-13485 certified US manufacturer of Capillus® brand photobiomodulating medical devices which are FDA-cleared for the treatment of androgenetic alopecia. Capillus laser therapy is clinically proven with published results. Other Capillus products include minoxidil, keratin fibers and hair care.

Low-level light therapy was first approved by the Food and Drug Administration in 2007 for the treatment of mild to moderate male pattern hair loss for a laser comb device designed to regrow hair. The emergence of the Capillus laser therapy cap has revolutionized the use of laser therapy for treatment of hair loss by making laser therapy more accessible and easier to use in order to create the most practical application in hair restoration.

Available today, readers are invited to visit https://www.capillus.com to learn more about the 6-minute per day laser therapy medical devices and hair regrowth products.

Capillus, LLC, a Leading US Medical Device Manufacturer of Photobiomodulation Devices, Changes Its Name to Curallux, LLC

Source

Previous Posts

Capillus Leads Innovation & Awareness at the 77th AAD Annual Conference

Capillus Leads Innovation & Awareness at the 77th AAD Annual Conference

/in /by

Capillus Leads Innovation & Awareness at the 77th AAD Annual Conference

Capillus, LLC is committed to staying abreast of medical advancements and research in hair restoration to increase awareness of biomodulation as a treatment method for hair loss.

The company showcased its premiere medical laser devices to an international audience of physicians specializing in dermatology at the American Academy of Dermatology 2019 AAD Annual Meeting in Washington, D.C.

Feedback from both physicians and customers is continuously taken into consideration by the Capillus team to innovate, upgrade and improve the product line. The company is committed to bringing awareness of laser therapy as a medical treatment for androgenic alopecia, which has long been used by medical professionals in hair restoration specialties but is still relatively new to dermatology. Capillus manufactures its devices from its ISO13485:2016 certified headquarters in Miami, Florida.

Also featured at the AAD annual meeting, Capillus announced their expanded Cap+ brand line of clinical hair care products, which contains natural ingredients to cleanse, exfoliate, and moisturize hair while promoting overall scalp health.

The expanded line of Cap+ products now includes a hair health supplement and 2% minoxidil for women, in addition to its 5% minoxidil for men and other hair care products. The popular Cap+ Bundle, which includes all Cap+ products, is applied to remove build-up in hair, restore vitality to lock in moisture, reduce inflammation while lubricating hair follicles as well as repair hair damage.

Capillus also congratulates Dr. Janice Lima-Maribona, a Miami, FL Dermatologist, for winning the CapillusRx (valued at $3,499) at the AAD annual meeting. The company generated a lot of buzz and interest from physicians specialized in dermatology with hair loss patients from around the world. Capillus urges interested physicians and specialists to become a part of the Capillus Physician Network, to contact the company directly at (844)-280-4680.

In furthering their commitment to hair science and research, Capillus will also be participating in the upcoming World Congress for Hair Research taking place abroad in Barcelona on April 24th, 2019. The congress will be a comprehensive, international hair research meeting for the advancement of knowledge in hair growth.

The company’s involvement will once again be integral to staying ahead of the curve with new advancements, research, and techniques for the development of hair growth in connection with international hair loss physicians.

About Capillus, LLC

Capillus, LLC offers both prescription as well as over-the-counter hair regrowth products and medical devices for both men and women suffering from hair loss. The Capillus premier product lines include low-level laser therapy (LLLT) devices that are FDA-cleared and manufactured in the US under the highest-quality certification standard for the medical device industry (ISO13485). Capillus also offers additional non-prescription clinical hair products for hair and scalp health under the Cap+ and RXCap+ brand. Capillus products are available directly to the public for at-home use and also to their network of physicians for office use.

For more information, visit: https://www.capillus.com/

Capillus Leads Innovation & Awareness at the 77th AAD Annual Conference

Source

 

Previous Posts

Megan Wilson Public Relations Named Capillus PR Agency of Record

Megan Wilson Public Relations Named Capillus PR Agency of Record

/in /by

Megan Wilson Public Relations Named Capillus PR Agency of Record

Megan Wilson Public Relations (“MWPR”) has been named PR Agency for Record by Capillus LLC, the leading producer of low-level laser therapy (“LLLT”) treatments for hair regrowth.

“Capillus® is a revolutionary company that utilizes FDA-approved methods to produce treatment options for hair loss,” said Megan Wilson, founder, and CEO of Megan Wilson Public Relations. “It is a pleasure to work with their team as the company continues to expand and innovate within the hair regrowth category.”

“Megan Wilson brings to the table over a decade of successful campaigns in the high-end beauty industry and the capabilities and expertise necessary to help Capillus® reinforce its industry-leading choice in hair regrowth treatment,” said Frances Piña Brea, Capillus® chief marketing officer.

Expressing excitement over the partnership, Carlos Piña, Capillus CEO said, “Anyone who cares about their appearance and the role it plays in their self-esteem or how others view them in society will benefit from Capillus products. Hair loss can be devastating psychologically. Our goal is to reach those for whom hair loss is a concern before it becomes an irreversible condition and working with MWPR will assist in sharing our message.”

With August being National Hair Loss Awareness month, MWPR and Capillus® kicked off their new brand awareness campaign with an appearance at Cosmoprof North America, the largest and most awarded beauty trade show in the Americas.

Later this month, Capillus® also attended the Aesthetic Everything Beauty Expo (http://www.aestheticeverythingbeautyexpo.com), hosted by celebrity Gretchen Christine Rossi (http://www.gretchenchristine.com) and attended by Dr. Doris Day (myclearskin.com) on August 10th and 11th, 2018 at the Phoenician Resort in Scottsdale, Arizona.

Up to 80% of men and 50% of women are affected by androgenetic alopecia – hair loss due to genetic factors. Capillus® is known as for their LLLT hats that can be purchased at a more affordable price than the traditional treatment cost associated with receiving LLLT at a licensed salon.

To complement the LLLT treatment, Capillus® has also created a line of clinical hair care products with minoxidil, one of the few FDA-approved treatment methods that are proven to work for hair regrowth.

About Capillus

Capillus, LLC offers prescription and over-the-counter hair regrowth products and medical devices for both men and women suffering from hair loss.

The Capillus premier product lines include low-level laser therapy (LLLT) tools that are FDA-cleared and manufactured in the US under the highest-quality certification standard for the medical device industry (ISO13485). Capillus also offers additional non-prescription clinical hair products for hair and scalp health. Capillus products are available directly to the public for at-home use and even to their network of physicians for office use. For more information, visit https://www.Capillus.com.

About Megan Wilson Public Relations

With almost two decades of experience producing events, as well as comprehensive and authoritative knowledge and experience managing public relations accounts in a variety of disciplines including fashion, fitness, publishing, real estate, and hospitality.

“MWPR” offers clients her vision, which is expertly brought to fruition by piecing together every element and detail to build a beautifully finished product. MWPR has been instrumental in successfully planning and executing openings, launches, and events, as well as large-scale public relations campaigns and media relations strategies for a variety of venues, personalities, and brands. Lifestyle,real estate and fashion brands including; The Salon Project by Joel Warren, The Jazz Age Lawn Party, Carol Alt, Beautique Restaurant, Dream Hotels, PIER59 STUDIOS, Ann Taylor, Gaiam, EBOOST, Corr Jensen, Vivienne Tam, Karim Rashid, Mike Ditka, Diamond Dallas Page, Colleen and Rodney Yee, and Mari Winsor.

For more information, visit http://www.meganwilsonpr.com.

Megan Wilson Public Relations Named Capillus PR Agency of Record

Source

Global Hair Loss And Growth Devices Market Analysis 2018

Global Hair Loss And Growth Devices Market Analysis 2018

/in /by

Global Hair Loss And Growth Devices Market Analysis 2018 – Capillus, WONTECH, Apira Science, HairMax and InnovaDerma

The research report “Hair Loss And Growth Devices Market: Global Industry Analysis 2018 -2023” offers comprehensive knowledge on the hair loss and growth devices market.

The report explores the essential factors that are likely to influence the global hair loss and growth devices market such as segment analysis, market dominant players, latest market trends, technology advancements, hair loss and growth devices business growth factors and restraints.

In addition, the report tracks the hair loss and growth devices market movements for more than ten years & provides a historical assessment of the market over the period 2013-2017, with forecast and projections offered for the period 2018-2023.

The hair loss and growth devices report additionally embraces the market dynamics contains a detailed explanation of current and future scenario of the global hair loss and growth devices market.

The report section highlights the hair loss and growth devices market driving sources, restraints, emerging market, worldwide industry news and policies, hair loss and growth devices market challenges and opportunities with their magnitudes across various regions.

To get clear insights hair loss and growth devices report includes segment wise definition of the market i.e. based on product type, hair loss and growth devices applications and regions. The scope of various market segments is calculated across the major geographies of North America, Latin America, Europe, Asia Pacific and the Middle East and Africa (MEA).

hairmax lasercomb hair loss

The sample copy of the report at https://market.biz/report/global-hair-loss-and-growth-devices-market-2018-mr/251576/#requestforsample

In the next section, hair loss and growth devices report offers a comparative study of dominant market players spread across the globe.

It provides details regarding company profile information, hair loss, and growth devices product introduction, product cost and gross margin, technology advancements in the production of hair loss and growth devices, collective market share analysis, geographic concentration, long term and short term strategies followed by hair loss and growth devices players.

The report examines opportunities in the global hair loss and growth devices market and gives updates related to the various segments of the market. The report offers the latest trends in the hair loss and growth devices industry as well as the performance of individual segment in the hair loss and growth devices market. This dominating data gives executives and other key individuals an accurate picture of global hair loss and growth devices market scenario.

Hair Loss And Growth Devices Market Competitive Landscape and Segmentation

Manufacturer InnovaDerma, Capillus, Freedom, Theradome, Apira Science, HairMax, and WONTECH
Types Lasers and LED
Applications Hair Loss Treatment Clinic and Homecare
Regions North America, India, Japan, Middle East & Africa, Europe, South America and China

Key Points of the Global Hair Loss And Growth Devices Market

– The hair loss and growth devices report is a valuable source provides a brief overview of the market and provides key statistics such as hair loss and growth devices market size, growth rate and revenue forecast in the assessment period 2018 to 2023.

– The report describes various aspects including hair loss and growth devices product specifications, capacity, demand and supply, loss and profit, material parameters, hair loss and growth devices upstream and downstream buyers information, emerging countries in global hair loss and growth devices market are broadly mentioned in the article.

– The hair loss and growth devices report provides insightful analysis of key market segments and their future scope.

– It gives a brief description of the hair loss and growth devices market dynamics and it’s impact to overall market growth.

– The comparative study of the hair loss and growth devices players will help all the market players to understand the recent trends and key business strategies to stay as a market leader in global hair loss and growth devices market.

– The report focuses on major application areas of global hair loss and growth devices market and important regions of the world where this market is possible to boom in the forecast period of 2018 – 2023.

Global Hair Loss And Growth Devices Market Analysis 2018

Source

New and Innovative Hair Loss Treatment Devices from HairMax Receives FDA Clearance

Capillus hair loss

Capillus Keratin Fibers Get a New Look and Name

/in /by

Capillus Keratin Fibers Get a New Look and Name

Since 2012 Capillus LLC has manufactured its premier line of laser therapy caps for hair regrowth under the Capillus® brand around the world. Shortly thereafter, Capillus introduced its lines of hair care and cosmetic products to further serve the needs of its hair loss customers.

In an effort to better reflect the company’s core products – the laser therapy caps – Capillus has rebranded the ancillary lines of products to the new brands: Cap+ and RXCap+, all of which can either be used independently or in conjunction with the FDA-cleared Capillus laser therapy caps.

Capillus clinical hair care products will now go by the Cap+ name. The Cap+ clinical hair care products use the best ingredients that gently cleanse, exfoliate, and moisturize hair for overall scalp health. The Cap+ clinical hair care product line includes shampoo, conditioner, activator, and revitalizer.

Capillus Keratin Fibers

The Capillus keratin hair fibers and holding spray will also have the Cap+ name. The Cap+ keratin hair fibers offer a temporary, quick fix that provides instant coverage for fuller hair in seconds. Thousands of miniature keratin fiber particles cling statically to hair, instantly concealing areas of thinning.

Capillus Extra Strength 5% Minoxidil Hair Regrowth Treatment will now be known as RXCap+ Extra Strength 5% Minoxidil Hair Regrowth Treatment which is available without a prescription and provides more hair regrowth than Minoxidil Topical Solution, 2%.

“The new name and look reflects Capillus’ desire to position our clinical hair care products and keratin hair fibers as a unique brand that can be used with Capillus’ laser therapy caps or by themselves for the treatment of pattern baldness,” said Capillus Marketing Director, Frances Piña-Brea.

Capillus wants to assure its customers that even though the name and look has changed, the actual product is still made from the same great, high-quality ingredients Capillus customers have known to trust. The Cap+ clinical hair care products, keratin hair fibers and RXCap+ Minoxidil are formulated to complement Capillus’ low-level laser therapy devices.

About Capillus, LLC

Capillus, LLC offers prescription and over-the-counter hair regrowth products and medical devices for both men and women suffering from hair loss.

The Capillus premiere product lines include low-level laser therapy (LLLT) devices that are FDA-cleared and manufactured in the US under the highest-quality certification standard for the medical device industry (ISO13485). Capillus also offers additional non-prescription clinical hair products for hair and scalp health under the Cap+ and RXCap+ brand. Capillus products are available directly to the public for at-home use and also to their network of physicians for office use.

For more information visit https://www.capillus.com.

Source

Capillus Announces Grand Opening of the First Capillus Store in Hong Kong

The CapillusRX Newest Innovation In Hair Restoration

/in /by

Capillus, LLC To Unveil Its Newest Innovation In Hair Restoration Laser Technology, The CapillusRX

Capillus, LLC has announced the release of CapillusRX™ Laser Therapy Cap with an industry leading 312 diodes. The new flex fitting cap has the most number of lasers and simultaneous coverage of any laser cap device on the market, offering 40 more lasers than the Capillus272 Pro™.

The device is the first laser therapy cap to be introduced with 6-minute daily treatment sessions. Capillus will unveil the CapillusRX™ at the International Society of Hair Restoration Surgeon’s Conference next week in Prague.

“We see the CapillusRX™ as a new generation of laser! We’re rolling out the most powerful laser device on the market today, in the same discreet design. Our device has 312 diodes, all fitted snugly into a new and comfortable hypoallergenic base.

Not only are we offering physicians a powerful laser cap, it’s also what we feel is the most comfortable,” says Carlos Pina, Founder and CEO of Capillus, LLC.

With the advent of continuous wave output technology, the CapillusRX™ requires the user to wear the cap for only six-minutes per day.

This is a vast improvement over the previous model, which needed to be worn 30-minutes on alternate days, making it now easier than ever for user compliance.

With continuous wave technology, the diode lifetime of the CapillusRX™ is also increased by 30%. Providing a steady power output to the laser diodes guarantees steadier diode energy output.

capillus capCapillusRX™ provides unparalleled, flexible comfort and is adaptable to different head sizes and shapes. Although the number of diodes have increased in the CapillusRX™ hat, there is no change in technology or indication of use. Therefore, there is no change to the product’s Food and Drug Administration (FDA) clearance.

The CapillusRX™ will not be sold directly to consumers as the company’s other models (Capillus82™, Capillus202™, Capillus272 Pro™). The CapillusRX™ model is only available exclusively through the Capillus physician network.

CapillusRX™ will be showcased for the first time at the International Society of Hair Restoration Surgery (ISHRS) conference in Prague, Czech Republic October, 4-7, 2017.

Readers are invited to visit https://www.capillus.com to learn more about Capillus hair regrowth products and laser therapy medical devices.

About Capillus, LLC

The Miami, Florida-based company, Capillus, LLC offers prescription and over-the-counter hair regrowth products and medical devices for both men and women suffering from hair loss. The Capillus premiere product lines include low-level laser therapy (LLLT) devices that are FDA-cleared and manufactured in the US under the highest-quality certification standard for the medical device industry (ISO13485).

Capillus also offers additional non-prescription clinical hair products for hair and scalp health. Capillus products are available directly to the public for at-home use and also to their network of physicians for office use.

For more information visit http://www.capillus.com.

Source

capillus

Published Clinical Study Shows Capillus Laser Therapy Safe and Effective at Treating Female Androgenetic Alopecia

/in /by

Published Clinical Study Shows Capillus Laser Therapy “Safe and Effective” at Treating Female Androgenetic Alopecia

A peer-reviewed study authored by Dr. Shelly Friedman, D.O., F.A.O.C.D. and supported by Patricia Schnoor, BSBA, confirms that low-level laser therapy (LLLT) with Capillus® may play a considerable role in the treatment of androgenetic alopecia for females, given the impartial evidence illustrating favorable hair regrowth results.

The research was published in the June 2017 edition of Dermatologic Surgery, the official journal of the American Society for Dermatologic Surgery, encouraging familiarity of LLLT as a practical method of fighting hair loss at home within the greater medical community.

Dr. Friedman of the Scottsdale Institute for Cosmetic Dermatology is a board-certified hair restoration surgeon with nearly three decades of experience treating over 15,000 patients with hair loss.

Patricia Schnoor is the head of quality assurance and governmental affairs at Capillus, overseeing the assembly, testing and quality control for Capillus’ line of FDA-cleared at-home laser caps.

The study’s circulation is expected to pave access to new international markets, allowing more individuals to undergo laser therapy hair loss treatment by way of physician prescription or recommendation.

“Performing and publishing clinical research under the rigor of a prestigious journal is of critical importance for doctors prescribing under evidence based practice guidelines,” said Fernando Bermúdez, Director of International Distribution at Capillus. “Published data is also a reference for increasingly savvy consumers wanting to make an educated purchase decision before committing to a long-term treatment.”

The purpose of this randomized controlled trial was to outline the effects of photobiomodulation, or laser light, on the hair follicle and surrounding tissues in patients suffering from hair loss. The subjects consisted of 44 healthy females ages 18 to 60 years who were recruited at two separate board–approved treatment sites.

The Capillus272™ Pro was used in the study under the alias of a “handi-dome” laser device. Using the discreet dome insert with laser diodes operating at 650 nm, active participants receiving LLLT with the Capillus272 Pro™ showed a 51 percent mean increase in hair counts compared to patients who used a seemingly identical yet defunct device.

The researchers concluded that low-level laser treatment administered for 30 minutes every other day for 17 weeks is both safe and effective in treating androgenetic alopecia in healthy females between the ages of 18 to 60 with Fitzpatrick skin Types I to IV and Ludwig–Savin Baldness Scale I-2 to II-2 baldness patterns.

No side effects or adverse reactions were reported by any subject at any time during the study.

For more, view the published abstract on Dermatologic Surgery, June 2017 – Volume 43 – Edition 6.

About Capillus

Capillus proudly offers hair regrowth products and medical devices recommended by hair restoration physicians around the world for both men and women with hair loss.

Capillus’s premiere product lines include low level laser therapy (LLLT) devices that are FDA-Cleared and manufactured in the USA under the highest quality certification standard for the medical device industry (ISO13485).  Capillus272 Pro, Capillus 202, and Capillus82 are light-weight and battery-operated laser therapy caps for at-home hair loss treatment, used 30 minutes every other day and worn discreetly under a sports cap.

The Capillus272 OfficePro is for laser therapy sessions administered in salons and clinics for clients seeking introductory treatment.  Capillus laser therapy devices feature more lasers than any other FDA-Cleared clinical device on the market for non-presrciption sale. Capillus offers additional products for clinical hair therapy and scalp health as well as keratin hair fibers for temporary concealment of thin hair. Readers are invited to visit http://www.capillus.com to learn more about Capillus hair regrowth products and laser therapy medical devices.

Source

Capillus Laser Cap

Michigan Hair Surgeon Now Providing Capillus® Laser Cap to Hair Loss Patients

/in /by

Michigan Hair Surgeon Now Providing Capillus® Laser Cap to Hair Loss Patients

A new, mobile low level laser therapy (LLLT) product has arrived at Accents Cosmetic Surgery to help men and women prevent the progression of hair loss.

Called the Capillus272 Pro™, this wearable laser therapy product is designed to increase the flow of blood and natural growth factors directly to hair follicles, helping patients who suffer with androgenetic alopecia develop a thicker and fuller head of hair.

“I highly recommend the Capillus272 to all of my patients who are in the market for a low-level laser light therapy device,” says Dr. Mark Berkowitz, founder of Accents Cosmetic Surgery. “It is simple to use, it has science behind it, and it’s something that I believe in and use myself.”

Capillus-LLLT-Device-Hair-Regrowth-Receives-FDA-Clearance

Capillus272 Pro™ is cleared by the FDA for the treatment of androgenetic alopecia, or hair loss, in men and women.

The laser cap has been shown to promote up to 51% increase in hair count, according to independently reviewed clinical studies available online at ClinicalTrials.gov.

Compared to other low level laser therapy options, Capillus272 Pro™ offers patients a high degree of discretion and convenience. The laser insert is placed beneath the cap of an ordinary hat or head covering, allowing patients to enjoy treatment without the worry of prying eyes. Capillus272 Pro™ is battery-operated and comes with a complimentary carrying case, allowing for consistent use around the house, at the office, and even on vacation.

“Compliance is very important for low level laser light therapy,” Dr. Berkowitz explains in a video interview. “If you aren’t going to use it, it’s never going to work. Well with a cap, it is so easy. I put it on, I drive to work with it 3 times a week or I watch TV with the cap on. If you use the Capillus®, it will work for you.”

In addition to low level laser therapy with Capillus272 Pro™, Dr. Berkowitz offers a variety of surgical and non-surgical hair restoration options for men and women who suffer with hair loss.

Dr. Berkowitz specializes in the NeoGraft hair transplant procedure, having performed hundreds of procedures totaling over 1.4 million grafts in the Michigan area.

For more information on hair restoration with Capillus272 Pro™, visit http://www.accentscosmeticsurgery.com.

Source